Literature DB >> 3808481

Inferior olive lesion induces long-term modifications of cerebellar inhibition on Deiters nuclei.

L Lopiano, T Savio.   

Abstract

The frequency of discharge of cerebellar Purkinje cells and lateral vestibular nuclear cells were recorded at different intervals of time after injection of 3-acetylpyridine (3AP), which destroys the inferior olivary nucleus. During the first few days, Purkinje cells showed an increase of simple spike firing, while Deiters cells showed a strong depression of their discharge. Recordings up to 3 months demonstrated, for both groups of cells, a recovery, whose time course is faster for Deiters cells than for Purkinje cells. A reduced inhibitory efficacy of Purkinje cells, as a consequence of climbing fibre deprivation, is suggested.

Entities:  

Mesh:

Year:  1986        PMID: 3808481     DOI: 10.1016/0168-0102(86)90016-7

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  4 in total

1.  Progressive limb ataxia following inferior olive lesions.

Authors:  K M Horn; A Deep; A R Gibson
Journal:  J Physiol       Date:  2012-10-01       Impact factor: 5.182

2.  Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss.

Authors:  Tong Wu; Jian Zhu; Amy Strickland; Kwang Woo Ko; Yo Sasaki; Caitlin B Dingwall; Yurie Yamada; Matthew D Figley; Xianrong Mao; Alicia Neiner; A Joseph Bloom; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Cell Rep       Date:  2021-10-19       Impact factor: 9.423

3.  Long-term effects of 3-acetylpyridine-induced destruction of cerebellar climbing fibers on Purkinje cell inhibition of vestibulospinal tract cells of the rat.

Authors:  L Karachot; M Ito; Y Kanai
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

4.  Dynamic characteristics of optokinetically controlled eye movements following inferior olive lesions in the brown rat.

Authors:  B J Hess; T Savio; P Strata
Journal:  J Physiol       Date:  1988-03       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.